Veeva Systems Inc. (ETR:VEE)
Market Cap | 38.50B |
Revenue (ttm) | 2.59B |
Net Income (ttm) | 708.04M |
Shares Out | n/a |
EPS (ttm) | 4.25 |
PE Ratio | 54.37 |
Forward PE | 33.72 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 5 |
Average Volume | 112 |
Open | 230.00 |
Previous Close | 238.90 |
Day's Range | 230.00 - 235.70 |
52-Week Range | 179.25 - 241.40 |
Beta | n/a |
RSI | 63.51 |
Earnings Date | Dec 3, 2025 |
About Veeva Systems
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ... [Read more]
Financial Performance
In 2024, Veeva Systems's revenue was $2.75 billion, an increase of 16.20% compared to the previous year's $2.36 billion. Earnings were $714.14 million, an increase of 35.84%.
Financial numbers in USD Financial StatementsNews
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today
Veeva Systems (NYSE: VEEV) has outperformed the market over the past 10 years by 13.89% on an annualized basis producing an average annual return of 26.53%. Currently, Veeva Systems has a market capi...
Veeva Systems partners with Gilead for Vault CRM

Gilead Sciences Commits to Veeva Vault CRM
Next generation CRM with deep capabilities and agentic AI PLEASANTON, Calif. , Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vau...
Calls of the Day: Abbvie, Vertex, Veeva and Vistra
The Investment Committee discuss the latest Calls of the Day.

Calls of the Day: Abbvie, Vertex, Veeva and Vistra
The Investment Committee discuss the latest Calls of the Day.

This Veeva Systems Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Veeva Systems: Competition Intensifying, Shares Remain Overvalued
Veeva Q2: Outpacing Salesforce's "Kill" Switch
Veeva Systems: Top-Line Momentum Should Continue To Accelerate
Veeva Systems Inc. (VEEV) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference (Transcript)
Get insights from Veeva Systems’ leadership on AI innovation, CRM migration benefits, and
Veeva Systems Inc (VEEV) Announces Participation in Upcoming Investor Conferences | VEEV stock news
Veeva Systems Inc (VEEV) Announces Participation in Upcoming Investor Conferences | VEEV stock news

Veeva to Present at Upcoming Investor Conference
PLEASANTON, Calif. , Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Citi's 2025 Global TMT Conference, New York, NY.
Veeva Systems Inc (VEEV) Expands Global Regulatory Collaboration with Veeva RIM | VEEV stock news
Veeva Systems Inc (VEEV) Expands Global Regulatory Collaboration with Veeva RIM | VEEV stock news

More Than 450 Companies Drive Speed to Market with Veeva RIM
Advanced regulatory capabilities and new industry partnerships accelerate collaboration with global health authorities PLEASANTON, Calif. , Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) tod...

Veeva Systems Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results
Veeva Systems Inc . (NYSE: VEEV) reported better-than-expected earnings for the second quarter on Wednesday . The company posted quarterly earnings of $1.99 per share which beat the analyst consensus...

Veeva Systems Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results
Veeva Systems Inc. VEEV reported better-than-expected earnings for the second quarter on Wednesday.
Veeva Systems: Overall, A Good Q2, With Only A Few Minor Issues
Veeva partners with Amgen to speed up clinical trials

Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
PLEASANTON, Calif. , Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation.
Veeva signals expanded opportunity in commercial cloud and AI following IQVIA resolution
Veeva Systems Inc. (VEEV) Q2 2026 Earnings Call Transcript
Veeva Systems Inc. 2026 Q2 - Results - Earnings Call Presentation

Veeva Systems Lifts Outlook on CRM Wins

Veeva Revenue Jumps 17% in Fiscal Q2
Veeva Makes A Bearish Move On One Pockmark In Its Quarterly Report
Veeva stock dipped late Wednesday after the firm reported adjusted earnings of $1.99 per share on $789.1 million in second-quarter sales.